Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.
Content updated: 2026-11-22 22:47:59
- Yesterday's Close
- $151.15
- Today's Open
- $152.00
- Today's High
- $152.52
- Today's Low
- $150.12
- Volume
- 1.54M shares
- 52-Week Range
- $137.03-$166.26
As of 2026-11-22 22:47:59, NOVARTIS AG-SPONSORED ADR (NVS) was quoted at $150.12, a change of -$1.03 (-0.68%) from the previous close. The day's range was $150.12–$152.52, and the 52-week range was $137.03–$166.26.
Why Is NOVARTIS AG-SPONSORED ADR (NVS) Stock Falling?
AI Stock Price AnalysisContent updated: 2026-11-20 21:10:34
Novartis ADR opened lower, briefly recovered to $153.18 and then faded to $151.25 near the bottom of the day's range, down 2.58% from the prior close on steady volume. Its mid-term outlook update narrowed the sales growth guide to about 5% through 2031, prompting a reassessment of the medium-term growth path.
About NOVARTIS AG-SPONSORED ADR (NVS)
- Ticker / Exchanges
- NVS / NYSE
- Industry / Sector
- Drug Manufacturers - General / Healthcare
- CEO
- Vasant Narasimhan
- Headquarters
- Basel,BS,CH
- Official Website
- https://www.novartis.com
- Listing Date
- 1996-11-07
Recent Company Events
- 2027-02-03Earnings Report · ExpectedOn 2027-02-03, the 2026/Q4 earnings report is expected to be released.
NOVARTIS AG-SPONSORED ADR (NVS) Derivatives Trading
Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.
NOVARTIS AG-SPONSORED ADR (NVS) Company Financials
Valuation and Shares
- Market Cap
- $284.14B
- P/E Ratio (TTM)
- 28.71
- P/B Ratio
- 7.63
- Shares Outstanding
- 1.88B shares
- Float Shares
- 1.84B shares
- Dividend Yield (TTM)
- 3.15%
Latest Reported Financials
2026 Q3 FinancialsReport Release Date: 2026-10-27
Operating Revenue (Actual)
$14.52B
Same Period Last Year: +1.14%
Earnings per Share (Actual)
$2.46
Same Period Last Year: +9.33%
Financials · Actuals
| Actual Value | 2022/Annual | 2023/Annual | 2024/Annual | 2025/Annual |
|---|---|---|---|---|
| Revenue | $43.46B | $46.66B | $51.72B | $56.67B |
| Net Profit | $6.95B | $14.85B | $11.94B | $13.98B |
| Operating Cash Flow | $14.23B | $14.45B | $17.61B | $19.14B |
NVS FAQ
What is the current stock price of NOVARTIS AG-SPONSORED ADR (NVS)?
Which exchange is NVS listed on?
How has NOVARTIS AG-SPONSORED ADR stock performed over the past month?
What is the market cap of NOVARTIS AG-SPONSORED ADR?
What are NOVARTIS AG-SPONSORED ADR's latest financial results?
What factors may affect the stock price of NOVARTIS AG-SPONSORED ADR (NVS)?
Risk Warning
Disclaimer






